Short-term debt and current portion of long-term debt

Merck & Co. Short-term debt and current portion of long-term debt decreased by 5.6% to $2.44B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryLeverage

SignalLower is better

VolatilityModerate

First reportedQ4 2025

Last reportedQ1 2026

How to read this metric

A significant increase may signal higher refinancing risk or a shift in capital structure, while a decrease indicates debt reduction or successful long-term refinancing.

Detailed definition

This represents the portion of total debt obligations, including bank loans, commercial paper, and the current portion o...

Peer comparison

Standard debt metric; peers report this as current portion of long-term debt or short-term borrowings.

Metric ID: other_debt_current

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$2.59B	$2.44B
QoQ Change	—	-5.6%

Range$2.44B – $2.59B

Short-term debt and current portion of long-term debt at Other Companies

Bristol-Myers SquibbBMY View metric

PfizerPFE View metric

Eli LillyLLY View metric

Frequently Asked Questions

What is Merck & Co.'s short-term debt and current portion of long-term debt?: Merck & Co. (MRK) reported short-term debt and current portion of long-term debt of $2.44B in Q1 2026.
What does short-term debt and current portion of long-term debt mean?: The amount of debt the company must repay within the next year.